Cellulose Ether Excellence — Trusted by 1000+ Enterprises Globally Get Free Sample
Pharmaceutical-grade HPMC, CMC, HEC, and selected cellulose ether solutions for binding, film forming, viscosity control, suspension stability, controlled release, and formulation consistency.
LANDERCOLL cellulose ethers support pharmaceutical formulation development with reliable excipient functionality — including tablet binding, coating film formation, matrix structure, viscosity adjustment, suspension support, and dosage-form stability across solid, semi-solid, and liquid dosage forms.
— HPMC · CMC · HEC · Tablet Binding · Film Coating · Controlled Release · Oral Films · Suspensions · USP/NF · Ph. Eur. · ChP
Tablet Binding
Film Coating
Controlled Release
Suspensions & GelsPharmaceutical excipient applications require suitable pharmaceutical-grade cellulose ether products with appropriate quality documentation. Not every cellulose ether grade is suitable for pharmaceutical use.
Before testing or commercial application, customers should confirm product specification, Technical Data Sheet, Safety Data Sheet, Certificate of Analysis, pharmacopoeia-related information, microbiological data, heavy metals information, residual solvent information, and other documentation required by the target dosage form, market, and internal qualification process. Final suitability must be confirmed by the customer’s formulation, quality, regulatory, and manufacturing teams.
HPMC, CMC, and HEC are the primary cellulose ethers used as pharmaceutical excipients. HPMC is the most versatile — supporting tablet binding, film coating, controlled-release matrices, oral films, and capsule applications. CMC is commonly used for viscosity control, suspension stability, and selected oral or ophthalmic liquid systems. HEC may be used in selected water-based systems for thickening and stabilization. Final polymer type, grade, and concentration must be confirmed through formulation testing and documentation review.
Binding · Coating · Release Control
Pharmaceutical excipients play an essential role in dosage form design. They support manufacturability, stability, appearance, release behavior, patient acceptability, and product consistency. In many solid, semi-solid, and liquid dosage forms, cellulose ethers are used because they can provide binding, film formation, viscosity control, gel formation, suspension stability, and controlled-release support.
LANDERCOLL provides suitable HPMC, CMC, HEC, and selected cellulose ether grades for pharmaceutical excipient applications. These products can be used in tablets, capsules, coatings, controlled-release systems, oral films, ophthalmic formulations, suspensions, gels, and other selected dosage forms.
A suitable cellulose ether grade helps formulators control powder cohesion, solution viscosity, coating performance, matrix hydration, suspension behavior, and product texture. Because pharmaceutical applications require strict quality control, grade selection and documentation review are critical before formulation evaluation begins.
Looking for pharmaceutical-grade cellulose ether for your excipient application?
Ask for a Product RecommendationCellulose ether is valued in pharmaceutical formulations because it provides water-soluble polymer functionality across a broad range of viscosity grades — allowing formulators to precisely adjust dosage form performance according to the target application, route of administration, and release requirement.
Pharmaceutical formulations vary widely depending on dosage form, active ingredient, process method, release target, and route of administration. The table below provides a general reference for common components where cellulose ether may play a functional role.
| Component | Function in Pharmaceutical Formulations |
|---|---|
| Active Pharmaceutical Ingredient (API) | Provides therapeutic function |
| Cellulose Ether (HPMC / CMC / HEC) | Binding, film forming, viscosity control, suspension, matrix support |
| Fillers / Diluents | Adjust dosage form weight, volume, and processability |
| Disintegrants | Support tablet breakup where required |
| Lubricants | Reduce friction during tablet compression or capsule filling |
| Plasticizers | Improve film flexibility in coating or oral film systems |
| Buffers / pH Modifiers | Adjust formulation pH and stability |
| Preservatives | Used in selected liquid or multi-dose systems |
| Stabilizers | Support chemical or physical stability |
| Other Functional Excipients | Adjust release, texture, appearance, taste, or process behavior |
LANDERCOLL provides pharmaceutical-grade HPMC, CMC, and HEC for excipient applications across tablets, coatings, controlled-release systems, suspensions, gels, and specialty dosage forms. All grade selections should be confirmed through formulation testing and customer qualification.
Hypromellose for binding, film formation & controlled release
HPMC is one of the most versatile cellulose ethers used in pharmaceutical excipient applications. Suitable pharmaceutical-grade HPMC can support tablet binding, film coating, controlled-release matrix formation, oral film systems, capsule applications, and selected liquid or semi-solid formulations.
Carboxymethyl cellulose for viscosity & suspension stability
CMC is used in selected pharmaceutical formulations where viscosity modification, suspension support, hydration behavior, and smooth texture are required. Suitable pharmaceutical-grade CMC may be used in oral suspensions, selected ophthalmic systems, gels, and other water-based dosage forms.
Hydroxyethyl cellulose for viscosity & stabilization
HEC may be used in selected pharmaceutical systems where thickening, viscosity control, stabilization, and water-based texture adjustment are required. Suitable pharmaceutical-grade HEC should be evaluated according to dosage form, route of administration, compatibility profile, and documentation requirements.
Different pharmaceutical dosage forms require different cellulose ether functions and grades. The table below provides a practical selection reference for formulators at the early stage of development.
Cohesion, granule strength, tablet hardness
Film formation, coating uniformity, viscosity control
Gel-layer formation, matrix integrity, release profile control
Shell support, viscosity control, filling consistency
Film formation, flexibility, dissolution behavior
Viscosity, lubrication feel, suspension stability
Suspension stability, viscosity, texture
Thickening, gel texture, consistency
Gel structure, viscosity, spreadability
Depends on formulation design and validation
Cellulose ether dosage in pharmaceutical formulations depends on dosage form, target function, viscosity grade, API properties, process method, and required performance. The following provides directional guidance for early-stage development.
These are starting references only. Final dosage should be confirmed through formulation trials, viscosity testing, mechanical testing, disintegration or dissolution testing, stability testing, process evaluation, and customer validation appropriate to the dosage form.
Depends on tablet hardness, binder efficiency, and process
Depends on coating solids, viscosity, and weight gain target
Depends on target release profile and matrix design
Depends on shell system or fill viscosity target
Depends on film thickness, flexibility, and dissolution
Depends on viscosity, clarity, comfort, and stability
Depends on suspension stability and pourability
Depends on viscosity, texture, and spreadability
In tablet formulations, cellulose ether can help improve powder cohesion, granule strength, tablet hardness, and mechanical integrity — supporting both wet granulation and direct compression processes depending on grade and concentration.
HPMC can form smooth and uniform films for tablet coating and oral film systems. Film quality depends on polymer grade, plasticizer selection, coating process parameters, drying conditions, and overall formulation design.
HPMC can hydrate and form a gel layer in hydrophilic matrix tablets, helping regulate water penetration, API diffusion, and matrix erosion. Viscosity grade and polymer concentration are the primary levers for tuning the release profile.
Cellulose ethers help adjust viscosity in liquid, semi-solid, coating solution, suspension, and gel formulations. Viscosity grade selection is critical for both processability during manufacturing and final product performance.
CMC, HPMC, and selected HEC grades can help suspend dispersed ingredients and reduce sedimentation in selected pharmaceutical systems — including oral suspensions and ophthalmic formulations.
Cellulose ether can improve texture, spreadability, lubrication feel, and product consistency in selected liquids, gels, and semi-solid systems — contributing to patient acceptability and ease of use.
A suitable cellulose ether grade helps maintain predictable hydration, viscosity, and formulation behavior during manufacturing and scale-up — reducing batch-to-batch variability and supporting process validation.
Cellulose ether can help improve many formulation challenges, but final dosage-form performance depends on the complete formulation, API properties, excipient compatibility, manufacturing process, stability profile, and regulatory validation.
Insufficient binder, poor granulation, weak cohesion.
HPMC or selected HEC supports binding and tablet cohesion.
Unsuitable polymer grade, poor plasticizer balance.
HPMC supports film formation and coating uniformity.
Wrong viscosity grade, poor matrix design.
HPMC supports matrix formation and release control.
Low viscosity, weak suspension system.
CMC, HPMC, or HEC supports suspension stability.
Unsuitable polymer type or dosage.
Cellulose ether helps adjust viscosity and texture.
pH, ionic strength, poor hydration, additive interaction.
Review grade compatibility and formulation conditions.
Excessive viscosity, poor flow, hydration issues.
Adjust grade, dosage, and addition sequence.
Wrong product grade or incomplete qualification.
Select suitable pharmaceutical-grade product with full documents.
Understanding the key variables that influence cellulose ether behavior is essential for successful pharmaceutical formulation development.
HPMC, CMC, and HEC differ in hydration behavior, viscosity, ionic character, and film-forming properties.
Affects binding efficiency, matrix gel strength, suspension stability, and coating sprayability.
Influences solubility, gelation behavior, hydration rate, and compatibility.
Solubility, dose loading, particle size, and stability affect excipient performance.
Affects hydration, viscosity, clarity, and stability — especially in liquid and ophthalmic systems.
Granulation, coating, casting, mixing, filling, and sterilization all influence performance.
Cellulose ether can absorb moisture — packaging and storage conditions affect powder flow and hydration.
Grade selection must align with pharmacopoeia standards and target market documentation requirements.
Choosing the right cellulose ether for pharmaceutical excipient use requires matching product type, grade, viscosity, documentation, and performance function to the target dosage form. The following questions guide early-stage selection.
What dosage form are you developing — tablet, coating, controlled-release matrix, capsule, oral film, suspension, gel, or ophthalmic product?
What function is the cellulose ether expected to perform — binder, film former, matrix polymer, thickener, suspending agent, or stabilizer?
Which cellulose ether type is required: HPMC, CMC, HEC, or another selected grade?
What viscosity range is required for the target application?
What API properties must be considered — solubility, dose, particle size, stability?
What manufacturing process will be used?
What pH, ionic strength, solvent system, or sterilization method applies?
What performance tests are required — dissolution, viscosity, hardness, stability?
What pharmacopoeia standards and documentation requirements apply?
What target market and regulatory pathway are involved?
LANDERCOLL can help review your pharmaceutical excipient application and recommend suitable cellulose ether grade options for evaluation.
Ask for Grade RecommendationLANDERCOLL pharmaceutical-grade cellulose ether is supplied in packaging suitable for protected transportation, storage, and pharmaceutical production handling.
| Parameter | Reference |
|---|---|
| Standard Pack Size | 25 kg per bag or drum (depending on grade) |
| Inner Liner | Moisture-protective inner liner |
| Palletized Packaging | Available upon request |
| Custom Packaging | Available for qualified supply cooperation |
Proper storage helps maintain powder flowability, hydration behavior, viscosity performance, and overall product stability throughout the supply chain.
25 kg · Sealed · GMP
If your formulation has weak tablet strength, poor coating film, unstable viscosity, inconsistent release, suspension settling, poor gel texture, process difficulty, or documentation mismatch, the cellulose ether type, grade, and dosage may need to be reviewed.
LANDERCOLL can help evaluate suitable HPMC, CMC, HEC, and selected cellulose ether options based on your dosage form, target function, viscosity requirement, API properties, manufacturing process, and documentation needs.
HPMC, CMC, and HEC grade selection for your specific dosage form and function
Viscosity direction recommendation based on application and process requirements
Tablet, coating, matrix, suspension, gel, and film application discussion
Compatibility review for API, excipient, pH, and process interactions
Documentation support including TDS, SDS, CoA, and regulatory compliance information
Sample and quotation communication for evaluation and commercial planning
Long-term qualified supply discussion for commercial-scale procurement
LANDERCOLL provides comprehensive pharmaceutical documentation to support excipient evaluation, supplier qualification, formulation development, quality review, and regulatory assessment.
| Document | Availability |
|---|---|
| Technical Data Sheet (TDS) | Available |
| Safety Data Sheet (SDS) | Available |
| Certificate of Analysis (CoA) | Available |
| Product Specification | Available |
| Pharmaceutical Grade Statement | Where applicable |
| Pharmacopoeia-Related Information (USP/NF, Ph. Eur., ChP) | Where applicable |
| Microbiological Data | Where applicable |
| Heavy Metals Information | Where applicable |
| Residual Solvent Information | Where applicable |
| Allergen / GMO / TSE-BSE Statements | Where applicable |
| Packaging and Storage Information | Available |
| Export-Related Documents | Where applicable |
HPMC, CMC, and HEC are the primary cellulose ethers used as pharmaceutical excipients. HPMC is the most widely used, covering tablet binding, film coating, controlled-release matrices, oral films, and capsule applications. CMC is commonly used for viscosity control, suspension stability, and selected ophthalmic or oral liquid systems. HEC may be used in selected water-based systems for thickening and stabilization.
HPMC may be used as a tablet binder, film-forming coating polymer, hydrophilic controlled-release matrix former, viscosity modifier in liquid systems, oral film polymer, and selected capsule-related excipient. Its versatility across multiple dosage forms makes it one of the most important pharmaceutical excipients in modern formulation development.
CMC may be used for viscosity control, suspension stability, smooth texture, lubrication feel, and selected oral liquid or ophthalmic systems. It is particularly associated with oral suspension formulations and artificial tear systems where hydration feel and viscosity-building performance are required.
HEC may be used in selected water-based pharmaceutical systems for viscosity control, thickening, stabilization, and texture adjustment. Its non-ionic character makes it useful in systems where ionic sensitivity is a concern. Customer validation and suitable pharmaceutical-grade documentation are required.
Yes. HPMC is widely used in hydrophilic matrix tablets where hydration and gel-layer formation help control drug diffusion and matrix erosion — enabling extended or modified-release profiles. Final release performance must be confirmed through dissolution testing and validated according to the target regulatory pathway.
Yes. Suitable cellulose ether grades — particularly HPMC — can support binding, cohesion, and tablet mechanical strength in selected tablet formulations, both in wet granulation and direct compression processes.
No. Pharmaceutical applications require suitable pharmaceutical-grade cellulose ether that meets recognized pharmacopoeia standards (USP/NF, Ph. Eur., ChP) and is supported by appropriate quality documentation. Industrial or food-grade materials do not meet the purity, safety, and documentation requirements for pharmaceutical dosage forms.
Typical documents include TDS, SDS, CoA, product specification, pharmacopoeia-related compliance information, microbiological data, heavy metals information, residual solvent information, and other quality or regulatory documents depending on the product grade, dosage form, and target market. LANDERCOLL can provide available documentation upon request.
Start with dosage form, target excipient function, cellulose ether type, viscosity grade, API properties, manufacturing process, pH and ionic conditions, documentation requirements, and regulatory pathway. LANDERCOLL can help recommend suitable grade directions for evaluation based on your specific formulation parameters.
Whether you develop tablets, film coatings, controlled-release systems, capsules, oral films, ophthalmic formulations, oral suspensions, pharmaceutical gels, or specialty dosage forms — LANDERCOLL can help you choose suitable pharmaceutical-grade HPMC, CMC, HEC, or selected cellulose ether products for reliable excipient performance and formulation consistency.
Our pharmaceutical-grade cellulose ether portfolio is supported by full GMP documentation, pharmacopoeia compliance information, and dedicated technical support — giving your formulation, quality, and regulatory teams the confidence to move from development to commercial qualification.
Pharmaceutical-Grade Cellulose Ethers for Tablet Binding, Film Coating, Controlled Release, Oral Films, Ophthalmic Formulations, and Specialty Pharmaceutical Excipient Applications.
English English 
العربية
Deutsch
Українська
Ελληνικά
Español
Español de Perú
Français
Magyar
Bahasa Indonesia
Italiano
Português
Türkçe
Русский
Nederlands
Slovenčina
Svenska
Български
Čeština
Dansk
Eesti
Suomi
日本語
한국어
Lietuvių kalba
Latviešu valoda
Norsk bokmål
Polski
Português do Brasil
Română
Slovenščina
